HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Role of a novel nociceptor autocrine mechanism in chronic pain.

Abstract
We have previously shown, in the rat, that neuropathic and inflammatory events produce a neuroplastic change in nociceptor function whereby a subsequent exposure to a proinflammatory mediator (e.g. prostaglandin E2 ; PGE2 ) produces markedly prolonged mechanical hyperalgesia. While the initial approximately 30 min of this prolonged PGE2 hyperalgesia remains PKA-dependent, it subsequently switches to become dependent on protein kinase C epsilon (PKCε). In this study we tested the hypothesis that the delayed onset, PKCε-mediated, component of PGE2 hyperalgesia is generated by the active release of a nucleotide from the peripheral terminal of the primed nociceptor and this nucleotide is then metabolized to produce adenosine, which acts on a Gi-coupled A1 adenosine receptor on the nociceptor to generate PKCε-dependent hyperalgesia. We report that inhibitors of ATP-binding cassette transporters, of ecto-5'-phosphodiesterase and ecto-5'nucleotidase (enzymes involved in the metabolism of cyclic nucleotides to adenosine) and of A1 adenosine receptors each eliminated the late, but not the early, phase of PGE2 -induced hyperalgesia in primed animals. A second model of chronic pain induced by transient attenuation of G-protein-coupled receptor kinase 2, in which the prolongation of PGE2 hyperalgesia is not PKCε-dependent, was not attenuated by inhibitors of any of these mechanisms. Based on these results we propose a contribution of an autocrine mechanism, in the peripheral terminal of the nociceptor, in the hyperalgesic priming model of chronic pain.
AuthorsLuiz F Ferrari, Emma Levine, Jon D Levine
JournalThe European journal of neuroscience (Eur J Neurosci) Vol. 37 Issue 10 Pg. 1705-13 (May 2013) ISSN: 1460-9568 [Electronic] France
PMID23379641 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Copyright© 2013 Federation of European Neuroscience Societies and John Wiley & Sons Ltd.
Chemical References
  • Adenosine A2 Receptor Antagonists
  • RNA, Small Interfering
  • Receptor, Adenosine A1
  • Protein Kinase C-epsilon
  • Grk2 protein, rat
  • G-Protein-Coupled Receptor Kinase 2
  • Dinoprostone
Topics
  • Adenosine A2 Receptor Antagonists (pharmacology)
  • Animals
  • Autocrine Communication
  • Chronic Pain (metabolism)
  • Dinoprostone (metabolism)
  • G-Protein-Coupled Receptor Kinase 2 (genetics, metabolism)
  • Hyperalgesia (metabolism)
  • Male
  • Nociceptors (drug effects, metabolism)
  • Protein Kinase C-epsilon (metabolism)
  • RNA, Small Interfering
  • Rats
  • Rats, Sprague-Dawley
  • Receptor, Adenosine A1 (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: